Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxytocin for shortening the active phase of labor
IRCT20130311012782N61Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2024
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 3, double-blind trial of oxytocin in Term delivery (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoints: Duration of the active phase of labor until delivery, Duration from 6 cm to 10 cm cervical dilation and 1 more. Started Nov 2024; status: completed.
02
Drugs
oxytocin
03
Conditions
Term delivery
Beyond the preview
Go deeper on IRCT20130311012782N61.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20130311012782N61.